Compare RCEL & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCEL | AMWL |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | 226 | N/A |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.0M | 92.0M |
| IPO Year | N/A | 2020 |
| Metric | RCEL | AMWL |
|---|---|---|
| Price | $4.30 | $5.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $7.88 | $7.42 |
| AVG Volume (30 Days) | ★ 216.1K | 121.8K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.69 | N/A |
| Revenue Next Year | $49.58 | $4.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.22 | $3.71 |
| 52 Week High | $10.28 | $9.15 |
| Indicator | RCEL | AMWL |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 56.78 |
| Support Level | $4.11 | $4.48 |
| Resistance Level | $4.57 | $5.74 |
| Average True Range (ATR) | 0.37 | 0.37 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 5.52 | 60.00 |
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.